Roar! Broker initiates coverage on Liontown shares with buy rating

This lithium share could be a high-risk, high-reward option for investors…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Liontown Resources Ltd (ASX: LTR) shares are pushing higher in afternoon trade.

At the time of writing, the lithium developer's shares are up over 2% to $1.35.

A person wears a roaring lion mask.

Image source: Getty Images

Why are Liontown shares rising?

Investors appear to have been buying Liontown shares on Tuesday in response to the release of a broker note out of Morgans.

According to the note, the broker has initiated coverage on the lithium developer with a speculative buy rating and $1.96 price target.

Based on its current share price, this implies potential upside of 45% for investors over the next 12 months.

Though, given its speculative rating, it is a high-risk option and thus only suitable for investors with a higher tolerance for risk.

What did the broker say?

Morgans notes that the company is a near-term developer of Australian spodumene and believes there's significant potential upside for Liontown shares if it can resolve its funding issues and avoid further significant cost blowouts. It commented:

LTR is an early stage developer with spodumene assets in central and southern WA. It is currently constructing the Katherine Valley (KV) project. Planned capacity is 3Mtpa – 4Mtpa (ROM tonnes) with first production expected in mid 2024. The KV project is supported by offtake agreements with several tier one customers.

The company and its flagship project have been impacted by cost increases however and additional funding will be required to complete it. We initiate with a SPECULATIVE BUY rating with potential 12-month upside of 44% to our $1.96 price target. However, we see LTR as a higher risk opportunity than its established peers.

The broker's preferred pick in the industry remains Allkem Ltd (ASX: AKE). It has an add rating and $15.40 price target on the lithium giant's shares. It stated:

We continue to prefer AKE amongst the lithium pure plays as we see a longer growth runway for production and greater potential valuation upside.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Old man working on his laptop at a cafe.
Broker Notes

Buy, hold, sell: CSL, BHP, Westpac shares

Let's start the new week with some fresh ratings from the experts. 

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Are Inghams and GYG shares a buy, hold or sell following earnings results

Is there any upside for these ASX shares?

Read more »

Worried man watching his smartphone.
Broker Notes

Experts name CBA and these ASX shares as sells today

Let's see why they are bearish on these popular names.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 109%! 3 reasons this ASX All Ords lithium stock is still a buy today

A leading expert forecasts more outperformance from this rocketing ASX lithium stock.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

ETF in grey and exchange traded fund in blue.
Broker Notes

Expert names 2 top ASX ETFs to buy today

A leading analyst expects these two ASX ETFs are well-placed to outperform.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Broker Notes

Bell Potter names the best ASX shares to buy in August

These could be the best of the best according to the broker.

Read more »

three excited doctors with hands in the air
Broker Notes

Buy, hold, sell: Super Retail, APA, Sonic Healthcare shares

As earnings season continues, brokers have issued new ratings on these 3 ASX 200 shares.

Read more »